LARVOL ThoughtLeader

Key Opinion Leader Tracking

KEEP PACE WITH YOUR THOUGHT LEADERS

WHAT IS THOUGHT LEADER / KOL TRACKING?

Follow Your Leaders. You’ve mapped out who the thought leaders or KOLs in your space are. Now you need to know what they’re doing. Tracking thought leader activity is essential to keeping your finger on the pulse of the market.

WHY TRACK THOUGHT LEADERS?

Beyond Mapping. Opinions and prescribing habits change. We track day-to-day activity for thought leaders, so you know where they’ll be, who they’re working with, and what they think about your product.

Engagement Opportunities. Our customized thought leader reports allow you to understand how key influencers are thinking about treatments and find opportunities to engage with them – whether that’s through personal appearances, involvement in a clinical trial, or another approach.

HOW DOES IT WORK?

Complete Coverage. We cover publications, events, clinical trials, media (including social media) and online CME courses to ensure you don’t miss an important event or opportunity to engage.

Automatic Reports + Searchable Database. You’ll receive email reports each week detailing activity on the thought leaders you select, plus an online database to search and track past activity.

Our Complete KOL Monitoring Solution Includes:

Events

• Events include conferences, symposiums, grand rounds, and lectures

• Coverage of 800+ conferences

Clinical Trials

• Completions and changes in status

• New trial initiations and enrollment updates

Publications

• Publications of trial results

• Reviews of agents and drug classes

• HEOR articles

Media

• All social media channels (Twitter, YouTube, LinkedIn)

• Quotes from KOLs in blogs, articles and websites

Online CME

• Continuing Medical Education course descriptions and dates

UNDERSTANDING THE REPORTS:

Associated Products

ONZETRA Xsail, Optinose sumaptriptan (sumatriptan intranasal) / Avanir, Optinose

Source

(Biz Journal) 01/29/2016

Excerpt or Summary

The food and Drug Administration has approved Onzetra Xsail, a migraine headache treatment… Dr. Stephen Silberstein…served as a principal investigator in the OptiNose clinical development program for Onzetra Xsail. ‘Many patients report that they are not fully satisfied with currently available migraine treatments,’ Silberstein said. ‘Onzetra Xsail will provide physicians and patients with a new alternative that offers relief in an innovative way – by using an exhaler.’

News Topic

Media Quote

NDA

TESTIMONIALS:

The Larvol ThoughtLeader reports are a tremendous resource to my team, helping us keep track of what each KOL is doing from multiple perspectives – clinical trials, publications, social media, important presentations – all captured in one, integrated source. Having this information at our fingertips is critical to maintaining quality customer relationships.

Chris Barnes

Senior Associate Director, Clinical Development Medical Affairs (CDMA) Effectiveness Boehringer Ingelheim

TRY IT FOR FREE

Ready to learn more? Gain access to information and start making strategic decisions about commercialization. Sign up for a free trial that includes all the activity we track for our customers for up to 15 thought leaders. It’s a great way to learn how active your KOLs are and whether tracking will provide benefits for your area. Fill out the form and a representative will contact you to get your free trial started.

REQUEST A DEMO

* required

REQUEST A SAMPLE REPORT

* required

CONTACT

Report Request
Demo Request

PHONE
415-874-3310
FAX
415-358-4466
EMAIL
info@larvol.com
ADDRESS
535 Mission St 14th Floor
San Francisco, CA 94105